{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cocrystal Pharma, Inc."},"Symbol":{"label":"Symbol","value":"COCP"},"Address":{"label":"Address","value":"19805 NORTH CREEK PARKWAY, BOTHELL, Washington, 98011, United States"},"Phone":{"label":"Phone","value":"+1 786 459-1831"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI)."},"CompanyUrl":{"label":"Company Url","value":"https://www.cocrystalpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"James Joseph Martin","title":"Co-Chief Executive Officer, CFO & Secretary"},{"name":"Sam Lee","title":"President & Co-Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}